Emphysema is an obstructive lung disease. It is one of the main conditions grouped under chronic obstructive pulmonary disease (COPD), and its hallmark is airflow that gets trapped in the lungs because damaged tissue can no longer push air out efficiently. The distinction matters because obstructive and restrictive diseases behave differently, feel different, and are managed differently.
Why Emphysema Is Obstructive
Lung diseases fall into two broad categories based on what goes wrong with airflow. In restrictive diseases, the lungs can’t fully expand, so they take in less air than normal. In obstructive diseases, air gets into the lungs but has trouble getting back out. Emphysema is obstructive because the structures responsible for pushing air out during exhalation are destroyed.
Your lungs contain millions of tiny air sacs called alveoli. These sacs are surrounded by elastic fibers, mainly a protein called elastin, that work like rubber bands. When you inhale, the air sacs stretch open. When you exhale, those elastic fibers snap back, squeezing air out. In emphysema, the walls between air sacs break down and the elastic fibers are destroyed. The sacs merge into larger, floppy pouches that can’t recoil. Air flows in but has no force pushing it back out, so it stays trapped.
This trapped air is what makes emphysema obstructive. The lungs slowly overfill, a process called hyperinflation. Over time, the damage spreads as neighboring fibers fail in a chain reaction: once one section of the wall ruptures, mechanical forces from normal breathing pull apart the weakened tissue around it, enlarging the damage further.
How Doctors Confirm the Obstruction
The standard test for distinguishing obstructive from restrictive disease is spirometry, a breathing test that measures how much air you can blow out and how fast. Two numbers matter most. FEV1 is the volume of air you can force out in one second. FVC is the total volume you can force out in one full breath. The ratio between them tells the story.
In a healthy person, that ratio is typically above 0.7, meaning you can blow out at least 70% of your total air in the first second. In obstructive diseases like emphysema, the ratio drops below 0.7 because trapped air slows the exhale. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) uses this threshold, confirmed after inhaling a bronchodilator medication, as the defining criterion for a COPD diagnosis.
In restrictive diseases, by contrast, both numbers drop roughly in proportion because the lungs simply hold less air. The ratio stays normal or even goes up. That’s one quick way to tell the two categories apart on a spirometry report.
What Happens Inside the Lungs
The damage in emphysema starts at a molecular level. The most widely accepted explanation involves an imbalance between enzymes that break down tissue and the proteins that normally keep those enzymes in check. Smoking is the most common trigger for this imbalance, though a genetic condition involving a protective protein called alpha-1 antitrypsin can cause it as well. Once the balance tips, elastic fibers in the alveolar walls degrade. The collagen that reinforces those walls can eventually weaken too, and once collagen fails, the wall itself ruptures.
As air sacs merge and surface area shrinks, the lungs lose their ability to transfer oxygen into the bloodstream. A test called DLCO measures this gas exchange capacity, and in emphysema it drops significantly. A DLCO below 60% of the predicted value is linked to higher mortality. This reduced gas exchange is what separates emphysema from chronic bronchitis, the other major form of COPD. A smoker with airway obstruction but normal gas exchange on testing typically has bronchitis rather than emphysema.
Signs of Air Trapping
The physical effects of trapped air become visible as emphysema progresses. The chest may develop an increased front-to-back diameter, sometimes called barrel chest, because the lungs remain partially inflated even at rest. Breathing rate increases in proportion to disease severity, and during flare-ups you may notice the muscles in the neck and between the ribs working harder to move air.
On a chest X-ray, hyperinflation shows up as a flattened diaphragm. Normally the diaphragm is dome-shaped, but when the lungs are chronically overfilled, the diaphragm gets pushed down and flattened. Doctors look for the diaphragm sitting at or below the seventh rib, or for the dome height measuring less than 1.5 centimeters. A widened space behind the breastbone is another sign, though it’s less reliable on its own. CT scans can also assess the extent of alveolar destruction directly, and recent COPD guidelines emphasize their role in evaluating emphysema severity.
How It Differs From Restrictive Disease
People sometimes confuse the two categories because both cause shortness of breath. The key difference is timing. In emphysema and other obstructive diseases, the main struggle is getting air out. Exhaling takes longer than normal, and you may feel like you can never fully empty your lungs. In restrictive diseases, such as pulmonary fibrosis or conditions affecting the chest wall, the struggle is getting air in. The lungs or surrounding structures are stiff, so each breath feels shallow.
There are rare cases where both patterns overlap. Someone with emphysema who also develops lung scarring, for instance, can show a mixed obstructive-restrictive pattern on spirometry. But emphysema on its own is purely obstructive. The destruction of elastic tissue, the air trapping, and the hyperinflation all point in the same direction: air goes in but can’t efficiently come back out.